1. Home
  2. CYTK vs ORA Comparison

CYTK vs ORA Comparison

Compare CYTK & ORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • ORA
  • Stock Information
  • Founded
  • CYTK 1997
  • ORA 1965
  • Country
  • CYTK United States
  • ORA United States
  • Employees
  • CYTK N/A
  • ORA N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • ORA Electric Utilities: Central
  • Sector
  • CYTK Health Care
  • ORA Utilities
  • Exchange
  • CYTK Nasdaq
  • ORA Nasdaq
  • Market Cap
  • CYTK 5.6B
  • ORA 4.6B
  • IPO Year
  • CYTK 2004
  • ORA 2004
  • Fundamental
  • Price
  • CYTK $37.73
  • ORA $89.11
  • Analyst Decision
  • CYTK Buy
  • ORA Buy
  • Analyst Count
  • CYTK 14
  • ORA 8
  • Target Price
  • CYTK $70.92
  • ORA $88.75
  • AVG Volume (30 Days)
  • CYTK 1.4M
  • ORA 525.4K
  • Earning Date
  • CYTK 08-07-2025
  • ORA 08-06-2025
  • Dividend Yield
  • CYTK N/A
  • ORA 0.54%
  • EPS Growth
  • CYTK N/A
  • ORA N/A
  • EPS
  • CYTK N/A
  • ORA 2.06
  • Revenue
  • CYTK $19,218,000.00
  • ORA $885,250,000.00
  • Revenue This Year
  • CYTK $27.08
  • ORA $9.65
  • Revenue Next Year
  • CYTK $652.09
  • ORA $14.25
  • P/E Ratio
  • CYTK N/A
  • ORA $43.29
  • Revenue Growth
  • CYTK 412.21
  • ORA 1.95
  • 52 Week Low
  • CYTK $29.31
  • ORA $61.58
  • 52 Week High
  • CYTK $61.38
  • ORA $91.81
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 55.97
  • ORA 64.66
  • Support Level
  • CYTK $36.71
  • ORA $88.90
  • Resistance Level
  • CYTK $38.54
  • ORA $91.81
  • Average True Range (ATR)
  • CYTK 1.33
  • ORA 1.28
  • MACD
  • CYTK -0.03
  • ORA -0.20
  • Stochastic Oscillator
  • CYTK 61.38
  • ORA 61.98

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About ORA Ormat Technologies Inc.

Ormat Technologies Inc is engaged in the geothermal and recovered energy power business. It is engaged in three business segments: Electricity Segment. where the company develops, builds, owns and operates geothermal, solar PV and recovered energy-based power plants in the United States and geothermal power plants in other countries and sell the electricity generated. Product Segment includes designing, manufacturing and selling equipment for geothermal and recovered energy-based electricity generation and providing services relating to the engineering, procurement and construction of geothermal and recovered energy-based power plants. Energy Storage Segment includes owning and operating grid-connected which provide capacity, energy and ancillary services directly to the electric grid.

Share on Social Networks: